Profile data is unavailable for this security.
About the company
Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.
- Revenue in SEK (TTM)19.85m
- Net income in SEK-7.57m
- Incorporated2003
- Employees5.00
- LocationRedsense Medical AB (publ)Storgatan 36HALMSTAD 302 43SwedenSWE
- Phone+46 35106030
- Fax+46 35106037
- Websitehttps://redsensemedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scandinavian Real Heart AB | 0.00 | -71.66m | 48.40m | 11.00 | -- | 0.6499 | -- | -- | -0.7028 | -0.7028 | 0.00 | 0.7678 | 0.00 | -- | -- | 0.00 | -67.22 | -24.27 | -78.30 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -701.98 | 0.0945 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
| Scandinavian ChemoTech AB | 4.11m | -19.26m | 48.90m | 6.00 | -- | 4.81 | -- | 11.89 | -1.28 | -1.28 | 0.2641 | 0.424 | 0.2327 | 0.3224 | 1.36 | 685,500.00 | -108.95 | -87.29 | -108.95 | -118.55 | 39.00 | 252.05 | -468.27 | -2,122.77 | -- | -15.73 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
| ProstaLund AB | 20.12m | -18.55m | 49.48m | 6.00 | -- | 0.9792 | -- | 2.46 | -0.2534 | -0.2534 | 0.2745 | 0.6598 | 0.3912 | 0.4325 | 11.14 | -- | -36.07 | -29.14 | -40.73 | -35.01 | 71.05 | 75.26 | -92.21 | -68.94 | 1.90 | -126.96 | 0.0255 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| Inhalation Sciences Sweden AB | 17.50m | -4.74m | 51.27m | 8.00 | -- | 3.96 | -- | 2.93 | -0.3575 | -0.3575 | 1.37 | 0.8541 | 1.12 | 0.9465 | 5.42 | 2,188,000.00 | -30.46 | -27.93 | -43.51 | -43.82 | 79.77 | 71.13 | -27.10 | -48.02 | 2.63 | -3.80 | 0.0776 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
| Clinical Laserthermia Systems AB | 10.83m | -70.90m | 56.51m | 7.00 | -- | 1.20 | -- | 5.22 | -15.31 | -15.31 | 2.00 | 6.00 | 0.2173 | 12.58 | 4.86 | -- | -144.45 | -123.49 | -259.50 | -312.95 | -392.44 | -1,084.16 | -664.90 | -1,625.03 | 2.06 | -30.97 | 0.0094 | -- | 31.99 | 35.55 | -12.92 | -- | 18.61 | -- |
| iZafe Group AB | 5.00m | -32.78m | 58.25m | 7.00 | -- | 2.94 | -- | 11.64 | -0.133 | -0.133 | 0.0201 | 0.0791 | 0.109 | 1.24 | 2.46 | 714,857.10 | -71.38 | -52.17 | -82.09 | -69.40 | -10.99 | -- | -655.02 | -487.50 | 0.6947 | -- | 0.1174 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
| Kontigo Care AB | 29.47m | 775.00k | 67.30m | 10.00 | 64.00 | 1.88 | 14.81 | 2.28 | 0.0328 | 0.0328 | 1.17 | 1.12 | 0.6807 | -- | 7.69 | -- | 1.79 | -0.4214 | 2.55 | -0.6195 | 68.84 | 66.31 | 2.63 | -0.5205 | -- | 4.00 | 0.093 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
| Glycorex Transplantation AB (publ) | 31.00m | -29.54m | 70.44m | 15.00 | -- | 1.82 | -- | 2.27 | -0.40 | -0.40 | 0.4197 | 0.5485 | 0.3978 | 0.7283 | 4.60 | 1,347,652.00 | -37.91 | -11.30 | -47.48 | -13.17 | 84.79 | 91.60 | -95.30 | -33.24 | 1.20 | -118.90 | 0.2046 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -39.77m | 83.87m | -- | -- | 1.37 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
| Redsense Medical AB (publ) | 19.85m | -7.57m | 94.64m | 5.00 | -- | 4.76 | -- | 4.77 | -0.5389 | -0.5389 | 1.41 | 1.42 | 0.7261 | 4.51 | 5.02 | 3,970,800.00 | -27.67 | -18.66 | -31.75 | -20.99 | 50.11 | 69.02 | -38.11 | -46.28 | 2.21 | -- | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| Luxbright AB | 952.90k | -25.38m | 95.44m | 10.00 | -- | 2.83 | -- | 100.16 | -0.2752 | -0.2752 | 0.0103 | 0.3653 | 0.0265 | -- | 1.99 | 95,290.00 | -70.61 | -61.39 | -81.90 | -70.36 | -947.28 | -559.15 | -2,662.94 | -2,459.34 | -- | -1,722.29 | 0.0061 | -- | 73.46 | -- | -20.07 | -- | -- | -- |
| Observe Medical ASA | 28.03m | -60.55m | 95.63m | 12.00 | -- | 0.8247 | -- | 3.41 | -1.05 | -1.05 | 0.4849 | 0.6063 | 0.1191 | 2.49 | 7.12 | 2,328,500.00 | -25.72 | -32.60 | -35.90 | -49.80 | 33.24 | 32.83 | -216.03 | -256.25 | 0.334 | -6.01 | 0.3204 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| ScandiDos AB | 65.08m | -4.85m | 102.62m | 34.00 | -- | 2.37 | -- | 1.58 | -0.1063 | -0.1063 | 1.43 | 0.7588 | 0.9573 | 0.4787 | 7.39 | -- | -7.14 | -13.82 | -13.39 | -23.95 | 82.54 | 82.49 | -7.45 | -17.09 | 0.4511 | -2.63 | 0.00 | -- | 6.70 | 4.01 | -24.27 | -- | 4.18 | -- |
| Nanexa AB | 28.91m | -70.62m | 127.83m | 19.00 | -- | 1.37 | -- | 4.42 | -0.8143 | -0.8143 | 0.3252 | 0.6854 | 0.2069 | -33.45 | 2.26 | 1,521,474.00 | -50.54 | -40.77 | -66.82 | -48.77 | 124.70 | 77.27 | -244.28 | -532.26 | 2.14 | -- | 0.0193 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
| Ortivus AB | 78.15m | -20.63m | 128.62m | 42.00 | -- | 8.08 | -- | 1.65 | -0.4655 | -0.4655 | 1.76 | 0.3529 | 1.00 | 3.36 | 4.76 | 1,953,650.00 | -26.44 | -2.41 | -51.70 | -4.63 | 33.88 | 42.46 | -26.39 | -1.77 | 0.5256 | -- | 0.4544 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
| Neola Medical AB | 0.00 | -9.04m | 139.60m | 7.00 | -- | 1.82 | -- | -- | -0.1536 | -0.1536 | 0.00 | 1.09 | 0.00 | -- | -- | 0.00 | -11.63 | -17.04 | -12.52 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
Data as of May 31 2024. Currency figures normalised to Redsense Medical AB (publ)'s reporting currency: Swedish Krona SEK
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Discover Capital GmbHas of 30 Jun 2023 | 750.00k | 0.00% |
| Swedbank Robur Fonder ABas of 29 Feb 2024 | 540.00k | 0.00% |
| Aktia Bank Plc (Investment Management)as of 30 Apr 2024 | 170.00k | 0.00% |
| Schroder Investment Management Ltd.as of 30 Jun 2023 | 141.14k | 0.00% |
| Aktia Fondbolag Abas of 30 Apr 2024 | 140.00k | 0.00% |
| AIFM Capital ABas of 31 Dec 2021 | 1.71k | 0.00% |
| Evli Fund Management Co. Ltd.as of 30 Apr 2024 | 1.00k | 0.00% |
More ▼
Data from 31 Dec 2021 - 30 Apr 2024Source: FactSet Research Systems Inc.
